What does OSI Systems do?
OSI Systems, Inc. is a Nasdaq-listed technology and manufacturing company that designs specialized electronic systems for security screening, medical monitoring, and high-performance optoelectronic applications. The company is best understood not as a single-product manufacturer, but as a portfolio of three operating platforms that share engineering, manufacturing, sensing, and service capabilities. Its official business pages describe a mission centered on creating solutions for a safer and healthier world, with critical applications in homeland security, healthcare, defense, and aerospace through the Security, Optoelectronics and Manufacturing, and Healthcare divisions.
How do the three businesses fit together?
Security, led by Rapiscan Systems and related businesses, provides checkpoint, baggage, cargo, vehicle, parcel, radiation, and people-screening equipment plus turnkey deployment and long-term service. Healthcare sells patient monitoring, diagnostic cardiology, and connected-care products. Optoelectronics and Manufacturing supplies optical sensors, photodetectors, subsystems, and electronics manufacturing services to outside original-equipment manufacturers while also supporting the other two OSI divisions. This internal supply relationship is strategically important: it gives OSI greater control over components, design changes, sourcing, and production scheduling than a pure systems integrator would have.
Why does the company matter?
OSI operates in markets where product failure has unusually high consequences. A screening system must detect threats reliably, a patient monitor must present accurate clinical information, and an aerospace or defense sensor must perform within narrow tolerances. These requirements create regulatory, technical, and reputational barriers to entry. They also lengthen sales and qualification cycles, which can make reported revenue uneven even when the long-term demand environment is favorable.
How does OSI Systems make money?
Revenue comes from a blend of product sales, large project contracts, component supply, manufacturing services, and aftermarket support. Security customers include airports, customs agencies, border authorities, law-enforcement organizations, critical-infrastructure operators, and commercial inspection users. Rapiscan’s official product catalogue spans baggage and parcel inspection, hold-baggage systems, people screening, trace detection, radiation detection, and cargo and vehicle inspection through its security-screening product portfolio.
Which segment drives the economic story?
Security is the largest profit engine and the principal source of backlog. Its economics combine hardware, software, integration, and service, but revenue timing can depend on government appropriations, site readiness, regulatory approvals, and customer acceptance. Optoelectronics and Manufacturing has lower margins but adds diversification, scale, and supply-chain leverage. Healthcare is smaller and has historically produced lower operating profitability, yet it provides recurring demand from installed medical systems and offers potential upside from product refreshes and connected-care adoption.
| Segment | Primary revenue | Customer base | Economic characteristic |
|---|---|---|---|
| Security | Systems, turnkey projects, service, software, parts | Government agencies, airports, ports, critical infrastructure | Largest segment; backlog and contract timing matter |
| Optoelectronics and Manufacturing | Sensors, subsystems, electronics manufacturing services | Aerospace, defense, medical, industrial, consumer OEMs | Diversified volume, lower margin, strategic vertical integration |
| Healthcare | Patient monitoring, cardiology systems, accessories, service | Hospitals, clinics, care networks | Installed-base and product-cycle economics |
Which segments and operating metrics matter most?
The freshest signal is fiscal third-quarter 2026 performance for the quarter ended March 31, 2026. The company reported revenue of $453.2 million, up 2% from $444.4 million a year earlier. Management emphasized that the comparison was distorted by unusually large Mexico-related Security revenue in the prior-year quarter; excluding those contracts, Security revenue increased 25% across the broader portfolio. Optoelectronics and Manufacturing revenue grew 10% year over year, while consolidated bookings pushed backlog to a record level.
Why are backlog and book-to-bill so important?
Backlog was approximately $1.9 billion at March 31, 2026, up from about $1.8 billion at December 31, 2025. Q3 book-to-bill was 1.3x, meaning new orders exceeded recognized revenue during the quarter. For an industrial technology company, this provides forward visibility, but it is not the same as guaranteed near-term sales. Contracts may be modified, delayed, funded in phases, or recognized over multiple periods. Researchers should therefore pair backlog with conversion, customer funding, and segment margin rather than treating the headline number as immediate revenue.
What does vertical integration contribute?
The Optoelectronics and Manufacturing division supports both external OEM customers and OSI’s internal product businesses. That creates a practical advantage in sensor availability, design iteration, and cost control. It also spreads factory utilization across end markets. However, manufacturing exposure adds inventory, labor, quality-control, and geographic supply-chain risk, particularly because OSI had substantial employment and production capacity across Asia, the Americas, and Europe at June 30, 2025.
What does the latest reporting period show?
The fiscal 2026 third-quarter release showed modest top-line growth but stronger adjusted earnings growth. GAAP diluted EPS declined 3% from $2.40 to $2.33, while non-GAAP diluted EPS rose 7% from $2.44 to $2.60. For the first nine months of fiscal 2026, revenue reached $1.302 billion, up 8% from $1.208 billion, GAAP diluted EPS was $5.71, and non-GAAP diluted EPS was $6.60.
| Metric | Q3 FY2026 | Q3 FY2025 | Interpretation |
|---|---|---|---|
| Revenue | $453.2M | $444.4M | 2% reported growth despite a difficult Security comparison |
| GAAP diluted EPS | $2.33 | $2.40 | 3% decline; GAAP costs and mix remain important |
| Non-GAAP diluted EPS | $2.60 | $2.44 | 7% growth points to underlying operating leverage |
| Operating cash flow | $14.5M | $81.6M | Quarterly working-capital timing created a sharp decline |
| Capital expenditure | $7.6M | $4.5M | Investment remained moderate relative to revenue |
How should cash flow be interpreted?
Quarterly operating cash flow fell to $14.5 million from $81.6 million, but the nine-month comparison was less severe: $93.8 million versus $97.0 million. Capital expenditure for the first nine months was $21.3 million, implying roughly $72.5 million of simple free cash flow before acquisitions and financing. This illustrates why one quarter can be misleading for a project-based company. Inventory purchases, customer advances, receivables, and milestone payments can move cash between periods without changing contract economics.
How did OSI Systems build its current position?
OSI’s present structure reflects decades of combining sensing technology, electronics manufacturing, and end-market systems. The company’s strategic evolution matters because the businesses reinforce one another: optoelectronics supplies core capabilities, Security converts them into high-value inspection platforms, and Healthcare applies related monitoring and connectivity expertise in clinical settings.
-
1987OSI was founded around optoelectronic components and specialized electronics, establishing the technical base for later vertical integration.
-
1997The company became publicly traded, expanding access to capital for acquisitions, product development, and global manufacturing.
-
2000sSecurity screening became a larger strategic pillar as airport and border inspection demand expanded after global security requirements tightened.
-
2010sOSI broadened cargo, vehicle, checkpoint, and service capabilities, increasing project scale and installed-base revenue opportunities.
-
2020–2024The company invested in advanced detection algorithms, real-time connectivity, and recurring service, while navigating pandemic disruption and supply constraints.
-
2024OSI issued convertible senior notes with an initial conversion price of about $191.98 per share, strengthening financing capacity while creating potential dilution considerations.
-
2025–2026Record revenue and backlog, leadership transition to CEO Ajay Mehra, and major homeland-security awards shifted the narrative toward scaled execution and conversion.
What did the leadership transition change?
Ajay Mehra became president and chief executive officer while founder Deepak Chopra continued as executive chairman. This structure preserves institutional knowledge and customer relationships while transferring day-to-day operating responsibility. For governance analysis, the important question is whether the transition improves execution discipline without slowing decision-making or blurring accountability between the chief executive and executive chair.
What gives OSI Systems a competitive advantage?
Security and medical products require certifications, testing, reliability records, and customer trust. New entrants cannot recreate these quickly.
Deployed systems create maintenance, upgrades, training, software, and replacement-part demand, deepening customer relationships.
Internal optical sensing and manufacturing improve design control, component access, and responsiveness across Security and Healthcare.
OSI can combine products, systems integration, local support, and long-term service for complex border, airport, and infrastructure programs.
Who are the main competitors?
Competition varies by product. In security screening, OSI competes with large global inspection and defense-technology suppliers in checkpoint, baggage, cargo, and trace detection. In Healthcare, it competes with larger patient-monitoring and diagnostic-equipment companies that have broad hospital relationships. Optoelectronics competes with specialist sensor manufacturers and contract electronics providers. The relevant comparison is therefore not company-wide market share, which OSI does not present as one unified figure, but product qualification, detection performance, installed base, service coverage, and total system cost.
| Competitive factor | OSI position | Pressure point |
|---|---|---|
| Technology performance | Proprietary imaging, sensing, algorithms, and system integration | Continuous R&D needed as threats and standards change |
| Customer switching cost | Training, certification, infrastructure, and service contracts support retention | Large tenders can still be highly price competitive |
| Global support | Sales, service, R&D, and manufacturing across multiple regions | Geopolitics, export controls, and local-content requirements add complexity |
| Manufacturing control | Internal optoelectronics and EMS capabilities | Factory utilization and supply-chain execution affect margins |
Is the moat durable?
The moat is strongest where OSI combines certified technology, a large installed base, service capability, and customer-specific integration. It is weaker in commoditized electronics manufacturing, where price, utilization, and customer concentration can dominate. The company must therefore keep moving toward differentiated systems and recurring support rather than relying on low-margin volume alone.
How financially strong is OSI Systems?
Fiscal 2025 revenue was $1.713 billion, up 11%, and GAAP diluted EPS was $8.71. Non-GAAP diluted EPS reached $9.36, up 15%. The fiscal 2025 Form 10-K provides the annual baseline: Security generated the majority of segment operating profit, while Healthcare profitability remained comparatively thin. Research and development expense totaled roughly $73.4 million in fiscal 2025, reflecting the need to keep products aligned with changing detection standards, medical workflows, and customer requirements.
What does the balance sheet allow?
Cash of $345.2 million at March 31, 2026 gives OSI flexibility for working capital, acquisitions, product development, and debt management. The company also has convertible notes and revolving-credit exposure, so a complete assessment should compare cash with debt, interest expense, and potential equity dilution. The notes provide low-cost capital and strategic flexibility, but conversion economics become more relevant when the share price is above the initial conversion level.
How should capital intensity be viewed?
Capital expenditure is modest relative to revenue because much of OSI’s value resides in engineering, intellectual property, customer qualification, and skilled production rather than heavy fixed assets. Yet working capital can be substantial. Large programs may require inventory, installation work, and receivables before final payment. Free cash flow can therefore lag earnings during growth periods and rebound when milestones are collected.
Who owns OSI Systems stock, and why does governance matter?
OSI has a conventional single class of common stock rather than a dual-class structure. Ownership is institutionally influenced, but founder involvement remains meaningful through Deepak Chopra’s executive-chair role and beneficial ownership. The latest 2025 proxy statement is the primary source for beneficial ownership, board composition, executive pay, and governance practices.
| Governance feature | Current signal | Why it matters |
|---|---|---|
| Leadership | Ajay Mehra, president and CEO; Deepak Chopra, executive chairman | Balances succession with founder continuity |
| Share structure | One common share class | Economic ownership and voting power are broadly aligned |
| Board oversight | Audit, compensation, governance, technology, and risk committees | Relevant for cyber, product, regulatory, and contract risk |
| Institutional ownership | Large passive and active institutions disclosed through official filings | Raises expectations for capital discipline and transparent execution |
| Executive incentives | Performance-based annual and long-term compensation | Researchers should compare targets with revenue, earnings, cash flow, and shareholder returns |
What should investors watch in the founder-to-successor transition?
The principal governance issue is not voting control but role clarity. Founder continuity can preserve relationships and technical culture, while a new CEO can improve operating cadence and accountability. The risk is that overlapping authority delays decisions or complicates succession. Compensation targets also matter: incentives focused only on adjusted earnings could encourage aggressive exclusions or acquisition activity, while balanced metrics including cash flow and long-term returns would better align with durable value creation.
What opportunities could expand OSI Systems?
The largest opportunity is sustained global demand for security inspection. Governments continue to upgrade airport checkpoints, border crossings, ports, parcel networks, and critical infrastructure as threat profiles evolve. OSI’s April 2026 homeland-defense award, along with subsequent cargo, vehicle, and service orders, demonstrates the scale available when a product platform wins a national program. Rapiscan’s global service network can then add recurring support after installation.
Where can operating leverage come from?
Operating leverage can emerge when higher Security volume runs through existing engineering, manufacturing, and service infrastructure. Service revenue may also carry better predictability than new equipment sales. In Optoelectronics, higher factory utilization can spread fixed costs across more units. In Healthcare, even modest revenue growth can improve profitability if product mix shifts toward differentiated systems and the division avoids excess selling expense.
What does management’s fiscal 2026 outlook imply?
Management reiterated fiscal 2026 revenue guidance of $1.825 billion to $1.867 billion and non-GAAP diluted EPS guidance of $10.30 to $10.55. At the midpoint, the revenue outlook implies continued full-year growth from fiscal 2025. The guidance also signals confidence that backlog and project execution can offset near-term disruptions, though the company explicitly noted uncertainty from a Department of Homeland Security shutdown and conflict in the Middle East.
What risks could weaken OSI Systems’ outlook?
OSI’s risk profile is concentrated in execution, government contracting, product performance, supply chains, and working capital. The fiscal 2025 10-K warns that failure of security equipment or algorithms to detect weapons, explosives, or other threats could create product and professional liability. This is an unusually severe tail risk because the consequences of failure extend beyond warranty expense to litigation, reputation, and future contract eligibility.
| Risk | Financial transmission | Metric to monitor |
|---|---|---|
| Government contract timing | Revenue delays, lower factory utilization, receivable build | Backlog conversion, book-to-bill, customer advances |
| Detection or product failure | Liability, recalls, remediation, reputational damage | Warranty expense, legal disclosure, contract renewals |
| Supply-chain disruption | Higher component cost, delayed shipments, excess inventory | Gross margin, inventory days, expedited freight |
| Working-capital volatility | Earnings fail to convert promptly into cash | Operating cash flow, receivables, inventory, advances |
| Healthcare underperformance | Low segment returns and possible restructuring charges | Healthcare revenue, segment income, product launches |
| Cybersecurity and export controls | Operational disruption, penalties, restricted sales | Incident disclosure, compliance cost, geographic mix |
Why is customer concentration complicated?
Large government projects can accelerate growth, but they create lumpiness and bargaining power for customers. A contract can be economically attractive yet still produce volatile quarterly comparisons. In addition, public-sector funding cycles, shutdowns, protests, compliance reviews, and political changes can delay orders. International projects add currency, export-control, sanctions, corruption-compliance, and local-partner risk.
What is the key financial risk?
The core financial risk is a divergence between reported earnings and cash conversion. If backlog grows but receivables and inventory rise faster, the company may need more borrowing despite apparent profitability. Conversely, strong customer advances can temporarily boost cash. The best analysis therefore uses multi-period operating cash flow and free cash flow rather than a single quarter.
Why does OSI Systems matter for valuation?
A discounted cash flow model for OSI should not extrapolate a single quarterly growth rate. The business is project-driven, acquisition-influenced, and sensitive to backlog conversion. A better framework begins with segment revenue, normalizes working capital over several years, and separates recurring service economics from equipment and turnkey projects. Security deserves the greatest weight because it generates most operating profit and carries the deepest backlog, while Optoelectronics provides diversification and Healthcare contributes optionality but also execution risk.
Which assumptions carry the most sensitivity?
The valuation is most sensitive to sustainable Security growth, consolidated operating margin, and free-cash-flow conversion. A modest change in terminal margin can materially alter value because Security revenue is large and fixed engineering costs create leverage. Working capital is equally important: a model that assumes accounting earnings immediately convert to cash will overstate value during periods of inventory and receivable growth.
Comparable-company analysis is also imperfect. Defense contractors, medical-device companies, electronics manufacturers, and security-technology suppliers have different margins and cyclicality. OSI’s diversified structure warrants a sum-of-the-parts mindset even when the final valuation is consolidated.
What is the key takeaway from OSI Systems analysis?
OSI Systems is a specialized industrial-technology platform whose central advantage is the combination of certified security systems, internal sensing and manufacturing capability, a global installed base, and recurring service potential. Fiscal 2025 revenue reached $1.713 billion, fiscal 2026 nine-month revenue rose 8% to $1.302 billion, and backlog reached approximately $1.9 billion at March 31, 2026. Those figures support a growth narrative, but the company’s true quality depends on conversion: converting orders into revenue, revenue into operating profit, and profit into cash.
The strongest part of the story is Security, where regulation, product qualification, customer trust, and service infrastructure create meaningful barriers. Optoelectronics and Manufacturing reinforces that moat through vertical integration and diversified OEM demand. Healthcare is strategically relevant but must demonstrate better profitability to earn the same valuation confidence.
Students and researchers should monitor eight items: backlog conversion, book-to-bill, Security operating margin, Optoelectronics growth, Healthcare segment income, multi-period operating cash flow, working-capital intensity, and leadership accountability during the CEO transition. The company’s official filing archive and annual report library provide the best ongoing evidence. The analytical conclusion is neutral but specific: OSI’s opportunity is substantial, yet its valuation should reflect contract timing, cash-conversion volatility, product-liability stakes, and the need for consistent execution across three very different businesses.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
